Teva Pharmaceutical Industries shares owned by Swiss National Bank
Quarter-by-quarter ownership of Teva Pharmaceutical Industries (TEVA) shares owned by Swiss National Bank
from 13F filings
Historical chart of Swiss National Bank investment in Teva Pharmaceutical Industries
Tip: Access up to 7 years of quarterly data
All positions including Teva Pharmaceutical Industries held by Swiss National Bank consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Teva Pharmaceutical Industries by Swiss National Bank
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $69M | 3.4M | 20.20 |
| 2025-06-30 | $61M | 3.6M | 16.76 |
| 2025-03-31 | $48M | 3.1M | 15.37 |
| 2024-12-31 | $69M | 3.1M | 22.04 |
| 2024-09-30 | $60M | 3.3M | 18.02 |
| 2024-06-30 | $54M | 3.3M | 16.25 |
| 2024-03-31 | $47M | 3.3M | 14.11 |
| 2023-12-31 | $37M | 3.5M | 10.44 |
| 2023-09-30 | $37M | 3.6M | 10.20 |
| 2023-06-30 | $30M | 4.0M | 7.53 |
| 2023-03-31 | $39M | 4.4M | 8.85 |
| 2022-12-31 | $41M | 4.5M | 9.12 |
| 2022-09-30 | $38M | 4.7M | 8.07 |
| 2022-06-30 | $35M | 4.7M | 7.52 |
| 2022-03-31 | $44M | 4.7M | 9.39 |
| 2021-12-31 | $35M | 4.3M | 8.01 |
| 2021-09-30 | $44M | 4.6M | 9.74 |
| 2021-06-30 | $46M | 4.7M | 9.90 |
| 2021-03-31 | $50M | 4.3M | 11.54 |
| 2020-12-31 | $41M | 4.2M | 9.65 |
| 2020-09-30 | $39M | 4.3M | 9.01 |
| 2020-06-30 | $54M | 4.4M | 12.33 |
| 2020-03-31 | $39M | 4.3M | 8.98 |
| 2019-12-31 | $38M | 3.8M | 9.80 |
| 2019-09-30 | $28M | 4.0M | 6.88 |
| 2019-06-30 | $37M | 4.0M | 9.23 |
| 2019-03-31 | $56M | 3.6M | 15.68 |
| 2018-12-31 | $55M | 3.5M | 15.42 |
| 2018-09-30 | $76M | 3.5M | 21.54 |
| 2018-06-30 | $90M | 3.7M | 24.32 |
| 2018-03-31 | $58M | 3.4M | 17.09 |
| 2017-12-31 | $67M | 3.5M | 18.95 |
| 2017-09-30 | $62M | 3.5M | 17.60 |
| 2017-06-30 | $115M | 3.5M | 33.22 |
| 2017-03-31 | $110M | 3.4M | 32.09 |
| 2016-12-31 | $132M | 3.6M | 36.25 |
Top funds holding Teva Pharmaceutical Industries
View all funds holding Teva Pharmaceutical Industries